PureTech Health plc (LON:PRTC – Get Free Report) shares passed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of GBX 166.97 ($2.21) and traded as low as GBX 143.20 ($1.89). PureTech Health shares last traded at GBX 146 ($1.93), with a volume of 1,728,492 shares changing hands.
PureTech Health Stock Performance
The stock has a market cap of £348.60 million, a price-to-earnings ratio of -634.78 and a beta of 1.02. The company has a debt-to-equity ratio of 47.27, a current ratio of 3.68 and a quick ratio of 2.51. The stock’s 50-day moving average is GBX 166.97 and its 200-day moving average is GBX 197.15.
Insider Transactions at PureTech Health
In related news, insider Robert Langer sold 233,098 shares of the company’s stock in a transaction on Monday, June 24th. The stock was sold at an average price of GBX 250 ($3.30), for a total value of £582,745 ($769,808.45). Insiders own 16.27% of the company’s stock.
About PureTech Health
PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.
Read More
- Five stocks we like better than PureTech Health
- Pros And Cons Of Monthly Dividend Stocks
- Palo Alto Analysts Drive it to New Highs: 50% Upside Is Possible
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Roblox’s Growth Beyond Kids: Stock Set for Major Moves
- The Role Economic Reports Play in a Successful Investment Strategy
- 5 Oversold Stocks to Buy Right Now
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.